NCT03753919 2026-03-11
DUTHY
Grupo Espanol de Tumores Neuroendocrinos
Phase 2 Terminated
Clinical Trials
35 trialsNCT07140757 2026-03-11
Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers
M.D. Anderson Cancer Center
Recruiting
NCT05575440 2026-02-27
Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid Cancer
Mayo Clinic
Recruiting
NCT07440290 2026-02-27
DETERMINE
Cancer Research UK
Phase 2/3 Not yet recruiting
NCT07391514 2026-02-06
Deep Learning-Based Intraoperative Dual-tracer Video Analysis of Sentinel Lymph Node Mapping for Metastasis Prediction in cN0 Papillary Thyroid Carcinoma
First Affiliated Hospital of Chongqing Medical University
Completed
NCT06235814 2026-02-05
MAPS
University of California, Los Angeles
Phase NA Completed
NCT06440850 2026-02-02
Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation
City of Hope Medical Center
Phase 2 Recruiting
NCT07376837 2026-01-29
PTC-RFA
University Health Network, Toronto
Phase NA Not yet recruiting
NCT05014698 2026-01-28
IDENTHY-K
Nantes University Hospital
Phase NA Terminated
NCT07357571 2026-01-22
Preoperative Prediction of Lymph Node Metastasis in T1N0M0 Papillary Thyroid Carcinoma by Using Contrast-enhanced Ultrasound
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Recruiting
NCT07354698 2026-01-21
MHI
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 4 Not yet recruiting
NCT07302672 2025-12-24
Humanistic Continuing Care Via WeChat for Patients Undergoing Thermal Ablation of Papillary Thyroid Carcinoma
China-Japan Friendship Hospital
Phase NA Recruiting
NCT05280379 2025-12-09
Trained Immunity in Thyroid Carcinoma and Colon Carcinoma
Radboud University Medical Center
Completed
NCT06623578 2025-12-03
Comparative Study of Transaxillary Robotic Thyroidectomy With MRND Versus Conventional Open Surgery in N1b PTC
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase NA Recruiting
NCT04624477 2025-11-28
Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer
University Health Network, Toronto
Active not recruiting
NCT03271892 2025-11-26
AS-PTC
University Health Network, Toronto
Active not recruiting
NCT05768178 2025-11-24
DETERMINE
Cancer Research UK
Phase 2/3 Recruiting
NCT05024929 2025-11-14
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
Children's Hospital of Philadelphia
Recruiting
NCT04759911 2025-11-13
Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT01709292 2025-10-27
Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT04544111 2025-10-07
PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT04462471 2025-09-08
Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT06439745 2025-09-02
cN0PTC
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Completed
NCT02973997 2025-08-29
Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC)
Academic and Community Cancer Research United
Phase 2 Completed
NCT05752669 2025-08-21
TEMPEST
Istituto Auxologico Italiano
Completed
NCT04197960 2025-08-05
Microwave Ablation and Surgical Resection for Micropapillary Thyroid Carcinoma
Chinese PLA General Hospital
Phase NA Completed
NCT07066644 2025-07-18
Intraoperative Pathologic Evaluation of Central Lymph Nodes in Papillary Thyroid Carcinoma
Seoul National University Hospital
Completed
NCT07042984 2025-06-29
RET-US
Fujian Medical University
Not yet recruiting
NCT03469011 2025-06-27
A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer.
AHS Cancer Control Alberta
Phase 1 Terminated
NCT06959641 2025-06-11
XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer
Northwestern University
Phase 2 Recruiting
NCT04129411 2025-05-20
Treatment of Papillary Thyroid Carcinoma With Radiofrequency Ablation
Mayo Clinic
Phase NA Completed
NCT06254859 2025-05-20
Intraoperative Neuromuscular Monitoring and Its Impact on Pre- and Postoperative Acoustic Outcomes in Thyroid Surgery
Fujian Medical University
Recruiting
NCT05003856 2025-04-02
Radiofrequency Ablation for the Treatment of Benign or Low Risk Thyroid Nodule
M.D. Anderson Cancer Center
Phase NA Terminated
NCT05410821 2025-04-01
Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid Cancer
The First Affiliated Hospital of Xiamen University
Phase 1 Completed
NCT06899347 2025-03-27
PRO-COMAND
University of Pisa
Phase NA Not yet recruiting